Top Markets
Coin of the day
LifeMD, Inc. LifeMD, Inc.

LifeMD, Inc.

LFMDP
株式のランク #6273
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects... LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
株価
$23.31
時価総額
$1.05B
変化(1日)
-0.81%
変化(1年)
-6.37%
US
取引 LifeMD, Inc. (LFMDP)

カテゴリー

LifeMD, Inc.(LFMDP)のP/E比率
March 2026 時点のP/E比率 TTM 12.04
LifeMD, Inc. の最新の財務報告および株価によると、現在の P/E (TTM) は 12.04 です。2023 年末時点での P/E は -13.65 でした。
LifeMD, Inc. の P/E 比率の履歴(2011 〜 2026)
各年末のP/E比率
P/E比率 変化
2026 (TTM) 12.04 -211.44%
2024 -10.80 -20.86%
2023 -13.65 922.40%
2022 -1.33 -21.69%
2021 -1.70 10.66%
2020 -1.54 -8.50%
2019 -1.68 -66.24%
2018 -4.99 -59.79%
2017 -12.40 49.85%
2016 -8.27 -86.13%
2015 -59.64 804.23%
2014 -6.60 -76.83%
2013 -28.47 188.12%
2012 -9.88 -33.88%
2011 -14.95 0.00%
類似企業や競合他社のP/E比率
企業 P/E比率 P/E比率の差
30.93 156.99%
HK
31.77 163.96%
BR
17.49 45.30%
JP
18.15 50.80%
CN
14.54 20.82%
JP
P/E比率の読み方

株価収益率(P/E Ratio)は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の(0に近い)P/Eは、損失が大きいことを示します。

P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。

10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。